Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
BridgeBio Pharma, Inc.Listing on record | Sell | $154M | SEC | ||
ADVANCED PHOTONIX INCListing on record | BuyD (derivative) | $4M | SEC | ||
ADVANCED PHOTONIX INCListing on record | BuyD (derivative) | $196M | Unusual size | SEC | |
PROCEPT BioRobotics CorpListing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
PROCEPT BioRobotics CorpListing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PROCEPT BioRobotics CorpListing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PROCEPT BioRobotics CorpListing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PROCEPT BioRobotics CorpListing on record | Buy | $14M | conv 61ClusterFirst in 12mo | SEC | |
PROCEPT BioRobotics CorpListing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
PROCEPT BioRobotics CorpListing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Zentalis Pharmaceuticals, Inc.Listing on record | Sell | $25.3M | SEC | ||
Adaptive Biotechnologies CorpListing on record | Sell | $122.7M | SEC | ||
Adaptive Biotechnologies CorpListing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Adaptive Biotechnologies CorpListing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Adaptive Biotechnologies CorpListing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Adaptive Biotechnologies CorpListing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Adaptive Biotechnologies CorpListing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Adaptive Biotechnologies CorpListing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Adaptive Biotechnologies CorpListing on record | Buy | $5M | conv 32Cluster | SEC | |
Adaptive Biotechnologies CorpListing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Adaptive Biotechnologies CorpListing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Urovant Sciences Ltd.Listing unverified | Buy | $55.8K | conv 23Cluster | SEC | |
Urovant Sciences Ltd.Listing unverified | Buy | $40.5K | conv 23Cluster | SEC | |
Urovant Sciences Ltd.Listing unverified | Buy | $55.1K | conv 23Cluster | SEC | |
Urovant Sciences Ltd.Listing unverified | Buy | $37.3K | conv 23Cluster | SEC |